Old Web
English
Sign In
Acemap
>
Paper
>
Tyrosinkinase-Inhibitoren wirksam bei EGFR-positivem NSCLC
Tyrosinkinase-Inhibitoren wirksam bei EGFR-positivem NSCLC
2017
J Greenhalgh
Keywords:
Immunology
Medicine
Oncology
Internal medicine
Pathology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]